J.F.Stoddart et al.
found: 463.1754; elemental analysis calcd (%) for C25H28O7: C 68.17, H
6.41; found: C 68.22, H 6.38.
9.89 (s, 1H), 7.83 (m, 4H), 7.75 (s, 2H), 7.36 (t, J=8.2 Hz, 1H), 7.33 (t,
J=8.2 Hz, 1H), 7.11 (d, J=8.2 Hz, 2H), 6.92 (dd, J=7.7 Hz, 2.7 Hz,
2H), 4.98 (s, 4H), 4.49 (s, 2H), 4.40 (t, J=4.5 Hz, 2H), 4.30 (m, 4H),
4.26 (t, J=4.5 Hz, 2H), 4.05 (t, J=4.5 Hz, 2H), 4.01 (t, J=4.5 Hz, 2H),
3.97 (t, J=4.5 Hz, 2H), 3.87 ppm (t, J=4.5 Hz, 2H); HRMS (MALDI):
m/z calcd for C37H35Br2NO10Na+ [M+Na]+: 834.0520; found: 834.0568.
Alcohol 21: This alcohol was obtained as a yellow wax (0.41 g, 79%).
1H NMR (CD3COCD3, 500 MHz, 298 K): d=7.29 (m, 2H), 6.96 (m, 3H),
6.57 (s, 1H), 6.55 (s, 1H), 4.36 (s, 4H), 4.15 (t, J=4.5 Hz, 2H), 3.85 (t,
J=4.5 Hz, 2H), 3.70–3.56 (m, 10H), 3.54 ppm (t, J=4.5 Hz, 2H);
13C NMR (CD3COCD3, 125 MHz, 298 K): d=158.9, 134.7, 129.2, 120.4,
116.6 (2), 116.5 (2), 114.4, 109.9, 72.6, 70, 3, 70.0, 69.4, 69.1 (2), 67.6, 67.5,
67.1, 61.0 ppm; MS (FAB): m/z (%): 516.05 (75) [M]+.
Dibromide 23: This dibromide was obtained as a yellow wax (0.15 g,
33%). 1H NMR (CD3COCD3, 500 MHz, 298 K): d=7.95 (s, 2H), 7.29
(m, 2H), 6.96 (m, 3H), 6.57 (s, 1H), 6.55 (s, 1H), 5.12 (s, 4H), 4.52 (s,
2H), 4.36 (s, 4H), 4.18 (t, J=4.5 Hz, 2H), 3.85 (t, J=4.5 Hz, 2H), 3.74–
3.62 ppm (m, 12H); 13C NMR (CD3COCD3, 125 MHz, 298 K): d=167.1,
166.3, 158.9, 137.3, 136.8, 134.7, 129.3, 128.4, 120.4, 116.6, 114.3, 70.3 (2),
69.4, 69.1, 69.0, 68.5, 67.2, 64.7, 38.5, 25.9 ppm; MS (FAB): m/z (%):
886.96 (20) [M]+.
Alcohol 22: This alcohol was obtained as a yellow wax (0.45 g, 83%).
1H NMR (CD3COCD3, 500 MHz, 298 K): d=9.92 (S, 1H), 7.90 (dd, J1 =
8.8 Hz, J2 =1.7 Hz, 2H), 7.16 (dd, J1 =8.8 Hz, J2 =1.7 Hz, 2H), 6.57 (s,
1H), 6.55 (s, 1H), 4.36 (s, 4H), 4.30 (t, J=4.5 Hz, 2H), 3.90 (t, J=4.5 Hz,
2H), 3.73 (m, 2H), 3.67–3.59 (m, 8H), 3.55 ppm (t, J=4.5 Hz, 2H);
13C NMR (CD3COCD3, 125 MHz, 298 K): d=190.2, 163.8, 134.8, 134.7,
134.7, 131.5, 130.2, 116.6, 116.5, 116.5 114.8, 72.6, 70, 3, 70.1, 69.2, 69.2
69.1, 67.8, 67.6, 67.5, 61.0 ppm; HRMS (MALDI): m/z calcd for
Dibromide 24: This dibromide was obtained as a yellow wax (0.32 g,
71%). 1H NMR (CD3COCD3, 500 MHz, 298 K): d=9.91 (s, 2H), 7.92 (s,
2H), 7.88 (t, J=8.8 Hz, 2H), 7.15 (t, J=8.8 Hz, 2H), 6.56 (s, 1H), 6.54 (s,
1H), 5.10 (s, 4H), 4.52 (s, 4H), 4.35 (m, 2H), 4.30 (t, J=4.5 Hz, 2H),
3.90 (t, J=4.5 Hz, 2H), 3.76–3.61 ppm (m, 10H); 13C NMR (CD3COCD3,
125 MHz, 298 K): d=190.2, 167.1, 166.3, 163.8, 137.3, 136.7, 134.7, 134.7,
130.5, 130.1, 128.4, 116.6, 116.5, 114.8, 70.3, 70.3, 69.2, 69.1, 69.1, 69.1,
68.5, 67.9, 64.7, 38.5, 25.9 ppm; MS (FAB): m/z (%): 914.95 (25) [M]+.
+
C23H28O7S4 [M]+: 544.0712; found: 544.0695.
Synthesis of the carboxylic acid derivative 11:[18] A mixture of 3,6-dime-
thylphthalimide (1.57 g, 8.97 mmol), tert-butyl 2-bromoacetate (1.92 g,
9.90 mmol), and K2CO3 (2.48 g, 17.90 mmol) in MeCN (50 mL) was
heated under reflux for 3 h.The resulting suspension was filtered and the
filtrate was evaporated to give a pale yellow solid, which was recrystal-
lized from EtOAc and hexanes (1:1) as colorless crystals (2.48 g, 95%).
Subsequently, a mixture of the obtained cyrstal (1.90 g, 6.57 mmol), NBS
(2.34 g, 13.15 mmol), and AIBN (20 mg, cat. amount) in CH2Cl2 (20 mL)
was heated under reflux for 4 h.The resulting suspension was filtered,
and the filtrate was evaporated and subjected to column chromatography
(SiO2: hexanes/EtOAc, 8:1) to give a white solid (1.40 g). The solid was
dissolved in CH2Cl2 (10 mL) and placed in an ice/water bath, and HNO3
(1.5 mL, 90%) was added dropwise into the solution. The mixture was
then stirred at room temperature for three more hours.The solvent was
evaporated under reduced pressure and the remaining solid was washed
with hexanes to give 11 as a white solid (1.09 g, 41% for three steps).
General procedure for the preparation of the self-complexing compounds
3–7·4PF6: A solution of the appropriate dibromide (0.36 mmol) and the
bipyridium salt 13·2PF6 (0.36 mmol) in DMF (5 mL) was stirred at room
temperature for eight days.In order to ensure full precipitation of the
purple salt, Et2O (50 mL) was added to the reaction mixture.The precipi-
tate was filtered off under reduced pressure and subjected to column
chromatography (SiO2: MeOH/NH4Cl (2m)/MeNO2 7:2:1).The fractions
containing the product were combined and concentrated.NH 4 PF6 was
added to precipitate the product as a solid.
Cyclophane 3·4PF6: This compound was obtained as a red solid (47 mg,
1
9%).Mp. .190 8C (decomp); H NMR of the SC-conformer (CD3COCD3,
500 MHz, 196 K): d=9.65 (d, J=5.4 Hz, 2H), 9.52 (d, J=5.4 Hz, 2H),
9.42 (d, J=5.4 Hz, 2H), 9.06 (brs, 2H), 8.75 (d, J=5.4, 2H), 8.58 (s, 2H),
8.52 (d, J=5.4, 2H), 8.50 (d, J=5.4, 2H), 8.50 (s, 2H), 8.18 (brs, 2H),
8.01 (s, 2H), 7.35 (t, J=8.4 Hz, 2H), 7.15 (d, J=8.4 Hz, 2H), 7.05 (d, J=
12.8 Hz, 2H), 7.01 (t, J=8.4 Hz, 1H), 6.41 (d, J=12.8 Hz, 2H), 6.22 (d,
J=12.8 Hz, 2H), 5.97 (d, J=12.8 Hz, 2H), 5.77 (d, J=7.4 Hz, 1H), 5.67
(d, J=7.4 Hz, 1H), 5.12 (brs, 2H), 4.59 (br, 2H), 4.51 (br, 2H), 4.32 (br,
2H), 4.11 (br, 2H), 3.92 (br, 4H), 3.82 (br, 4H), 2.53 (br, 1H), 2.02 ppm
(d, J=7.4 Hz, 1H); HRMS (ESI): m/z calcd for C60H57F24N5O9P4S4
[MꢀPF6]+: 1554.1606; found: 1554.1638.
1
M.p. 228.0–230.58C; H NMR (CDCl3, 500 MHz, 298 K): d=7.90 (s, 2H),
5.07 (s, 4H), 4.44 ppm (s, 2H); 13C NMR (CDCl3, 125 MHz, 298 K): d=
167.7, 166.3, 137.3, 136.7, 128.5, 38.2, 25.8 ppm; MS (EI): m/z (%): 389.0
(25) [M]+, 309.0 (100) [MꢀBr]+; elemental analysis calcd (%) for
C12H9Br2NO4: C 36.86, H 2.32, N 3.58; found: C 37.07, H 2.21, N 3.58.
General procedure for the preparation of the dibromides 12,18,19,23,
and 24: A mixture of the appropriate alcohol (0.50 mmol), the carboxylic
acid derivative 11 (0.55 mmol), 1,3-dicyclohexylcarbodiimide (1.0 mmol),
and 4-dimethylaminopyridine (catalytic amount) in CH2Cl2 (20 mL) was
stirred overnight at room temperature.The resulting suspension was fil-
tered, and the filtrate was evaporated and subjected to column chroma-
tography (SiO2: hexanes/EtOAc 1:1) to give the dibomide.
Cyclophane 4·4PF6: This compound was obtained as a purple solid
(96 mg, 17%).Mp..220
8C (decomp); 1H NMR of the major isomer
(CD3COCD3, 500 MHz, 253 K): d=9.69 (d, J=5.4 Hz, 2H), 9.63 (d, J=
5.4 Hz, 2H), 9.52 (d, J=5.4 Hz, 2H), 9.23 (d, J=5.4 Hz, 2H), 8.65 (brd,
2H), 8.54 (s, 2H), 8.45 (brd, 2H), 8.36 (m, 4H), 7.98 (s, 2H), 7.88 (s,
2H), 7.10 (t, J=8.4 Hz, 2H), 6.82 (t, J=8.4 Hz, 1H), 6.75 (d, J=12.8 Hz,
2H), 6.74 (s, 1H), 6.61 (d, J=8.4 Hz, 2H), 6.20 (s, 1H), 6.13 (d, J=
12.8 Hz, 2H), 6.02 (d, J=12.8 Hz, 2H), 5.94 (d, J=12.8 Hz, 2H), 4.72 (s,
2H), 4.62 (brd, 2H), 4.30 (m, 4H), 4.23 (s, 2H), 4.15 (brt, 2H), 4.05 (br.
t, 2H), 3.97 (brt, 2H), 3.75 (brt, 2H), 3.68 (brt, 2H), 3.59 (brt, 2H), 2.77
(d, J=8.4 Hz, 1H), 2.67 ppm (d, J=8.4 Hz, 1H); HRMS (ESI): m/z calcd
for C64H59F24N5O9P4 [MꢀPF6]+: 1476.2869; found: 1476.3189; HRMS
(ESI): m/z calcd for C64H59F24N5O9P4 [Mꢀ2PF6]2+: 665.6793; found:
665.6796.
Dibromide 12: This dibromide was obtained as a white wax (0.26 g,
71%). 1H NMR (CD3COCD3, 500 MHz, 298 K): d=7.92 (s, 2H), 7.30 (t,
J=8.5 Hz„ 2H), 6.96 (m, 3H), 6.90 (s, 4H), 5.09 (s, 4H), 4.51 (s, 2H),
4.37 (t, J=4.5 Hz, 2H), 4.17 (t, J=4.5 Hz, 2H), 4.12 (t, J=4.5 Hz, 2H),
4.07 (t, J=4.5 Hz, 2H), 3.90, (m, 4H), 3.81 ppm (m, 4H); 13C NMR
(CD3COCD3, 125 MHz, 298 K): d=167.1, 166.2, 158.9, 153.1, 137.3,
136.7, 129.2, 128.4, 120.4, 115.4, 115.3, 114.3, 69.6, 69.5, 69.4, 68.5, 67.8,
67.2, 64.7, 38.4, 25.8 ppm; HRMS (MALDI): m/z calcd for C32H33Br2NO9-
Na+ [M+Na]+: 756.0414; found: 756.0411.
Dibromide 18: This dibromide was obtained as
a yellow semisolid
(0.30 g, 77%). 1H NMR (CDCl3, 500 MHz, 298 K): d=7.91, 7.88 (2d, J=
8.5 Hz, 2H), 7.64 (s, 2H), 7.40–7.29 (m, 4H), 7.00–6.97 (m, 3H), 6.87 6.86
(2d, J=7.5 Hz, 2H), 4.94 (s, 4H), 4.49 (s, 2H), 4.44 (t, J=4.5 Hz, 2H),
4.33 (t, J=4.5 Hz, 2H), 4.30 (t, J=4.5 Hz, 2H), 4.21 (t, J=4.5 Hz, 2H),
4.10 (t, J=4.5 Hz, 2H), 4.04 (t, J=4.5 Hz, 2H), 4.00 (t, J=4.5 Hz, 2H),
3.90 ppm (t, J=4.5 Hz, 2H); 13C NMR (CDCl3, 125 MHz, 298 K): d=
167.0, 166.3, 158.7, 154.2, 154.1, 137.0, 136.4, 129.3, 128.2, 126.6, 125.1,
125.0, 120.8, 114.6, 114.6, 114.5, 105.7, 69.9, 69.9, 69.7, 69.0, 67.9, 67.8,
67.4, 64.9, 38.7, 25.7 ppm; MS (EI): m/z (%): 785.1 (10) [M]+; HRMS
(MALDI): m/z calcd for C36H35Br2NO9 [M]+: 783.0679; found: 783.0685.
Cyclophane 5·4PF6: This compound was obtained as a purple solid
(77 mg, 13%).Mp..214
8C (decomp); 1H NMR of the major isomer
(CD3COCD3, 500 MHz, 227 K): d=9.82 (s, 1H), 9.46 (d, J=6.2 Hz, 2H),
9.37 (d, J=6.2 Hz, 2H), 9.15 (d, J=6.2 Hz, 2H), 8.92 (d, J=6.2 Hz, 2H),
8.83 (s, 2H), 8.47 (s, 2H), 8.22 (s, 2H), 8.00 (d, J=6.2 Hz, 2H)), 7.93 (d,
J=6.2 Hz, 2H), 7.88 (d, J=6.2 Hz, 2H), 7.80 (d, J=8.4 Hz, 2H), 7.60
(br, 2H), 7.15 (d, J=8.4 Hz, 2H), 7.10 (d, J=12.8 Hz, 2H), 6.54 (d, J=
8.4 Hz, 2H), 6.47 (t, J=8.4 Hz, 1H), 6.35 (d, J=8.4 Hz, 1H), 6.31 (d, J=
12.8 Hz, 2H), 6.19 (t, J=8.4 Hz, 1H), 6.16 (d, J=12.8 Hz, 2H), 6.00 (d,
J=12.8 Hz, 2H), 5.28 (s, 2H), 4.65–4.38 (m, 12H), 4.19 (br, 2H), 4.03
(br, 2H), 2.71 (d, J=8.4 Hz, 1H), 2.64 ppm (d, J=8.4 Hz, 1H); HRMS
Dibromide 19: This dibromide was obtained as a yellow solid (0.39 g,
95%). M.p. 65.0–67.08C; 1H NMR (CD3COCD3, 600 MHz, 298 K): d=
382
ꢁ 2005 Wiley-VCH Verlag GmbH & Co.KGaA, Weinheim
Chem. Eur. J. 2005, 11, 369 – 385